Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharma Mar SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharma Mar SA, Medical Devices Deals, 2012 to YTD 2018 10
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pharma Mar SA, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Pharma Mar Enters into Distribution Agreement with Impilo Pharma 12
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 13
Merger 14
Zeltia Merges with Pharma Mar in Reverse Merger Transaction 14
Licensing Agreements 15
Pint Pharma International Enters into Licensing Agreement with Pharma Mar 15
Seattle Genetics Enters into Licensing Agreement with Pharma Mar 16
Pharma Mar Enters into Licensing Agreement with Megapharm 17
Pharma Mar to Enter into Licensing Agreement with Boryung Pharma 18
Boryung Pharm Enters into Licensing Agreement with Pharma Mar 19
Eczacibasi Enters into Licensing Agreement with Pharma Mar 20
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 21
Boryung Pharma Enters into Licensing Agreement with Pharma Mar 22
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 23
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 24
TTY Biopharm Enters into Licensing Agreement with PharmaMar 25
PharmaMar Enters into Licensing Agreement with Chugai Pharma for Aplidin 26
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 27
Equity Offering 28
Pharma Mar Plans to Raise Funds through Public Offering of ADS 28
Pharma Mar SA – Key Competitors 29
Pharma Mar SA – Key Employees 30
Pharma Mar SA – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 33
Financial Announcements 33
Oct 30, 2018: PharmaMar reports net profit of €5 million at the end of the third quarter of 2018 33
Jul 26, 2018: PharmaMar group obtained a net profit of €3 million in the first half of 2018 34
Apr 26, 2018: Pharmamar Group Reports First Quarter Financial Results 35
Feb 28, 2018: PharmaMar group announces 2017 earnings results 36
Oct 24, 2017: Pharma Mar group revenues totalled €140 million in the first nine months of the year 37
Jul 26, 2017: Pharma Mar group reports first half financial results 38
Apr 27, 2017: PharmaMar Group reports €45.5 million in revenues (+8%) 39
Feb 24, 2017: PharmaMar continues to execute commercially in 2016, adds new partner for pipeline asset, and sees pipeline progress 40
Corporate Communications 42
Oct 01, 2018: PharmaMar names Ali Zeaiter as new Director of Clinical Development 42
Government and Public Interest 43
Mar 29, 2017: The success of sarcoma treatment, seen by prestigious international oncologists 43
Product News 45
06/16/2017: PharmaMar Will Commercialize PM1183 With the Trade Name of Zepsyre 45
04/27/2017: PharmaMar demonstrates its progress in R&D in New York 46
04/04/2017: PharmaMar Presents New Data on Lurbinectedin at the AACR Congress 47
Clinical Trials 48
Sep 19, 2017: PharmaMar Starts Clinical Studies with a New Compound –PM14- in Patients with Solid Tumors 48
Jun 13, 2017: PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers 49
May 18, 2017: PharmaMar Announces new data on Lurbinectedin during ASCO 2017 50
Other Significant Developments 51
Jul 30, 2018: Immedica – a platform for pan-European niche specialty pharma launch, commercialization and distribution services 51
Jun 28, 2018: PharmaMar’s 2017 Group Annual General Shareholder’s’ meeting 52
Jun 29, 2017: PharmaMar Group reviews 2016 at its annual general shareholders meeting 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Pharma Mar SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharma Mar SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharma Mar SA, Deals By Therapy Area, 2012 to YTD 2018 9
Pharma Mar SA, Medical Devices Deals, 2012 to YTD 2018 10
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Pharma Mar Enters into Distribution Agreement with Impilo Pharma 12
Pharma Mar Enters into Agreement with Spanish National Cancer Research Centre 13
Zeltia Merges with Pharma Mar in Reverse Merger Transaction 14
Pint Pharma International Enters into Licensing Agreement with Pharma Mar 15
Seattle Genetics Enters into Licensing Agreement with Pharma Mar 16
Pharma Mar Enters into Licensing Agreement with Megapharm 17
Pharma Mar to Enter into Licensing Agreement with Boryung Pharma 18
Boryung Pharm Enters into Licensing Agreement with Pharma Mar 19
Eczacibasi Enters into Licensing Agreement with Pharma Mar 20
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 21
Boryung Pharma Enters into Licensing Agreement with Pharma Mar 22
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 23
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 24
TTY Biopharm Enters into Licensing Agreement with PharmaMar 25
PharmaMar Enters into Licensing Agreement with Chugai Pharma for Aplidin 26
PharmaMar Enters into Licensing Agreement with GP Pharm for Politrate Leuprorelin 27
Pharma Mar Plans to Raise Funds through Public Offering of ADS 28
Pharma Mar SA, Key Competitors 29
Pharma Mar SA, Key Employees 30
Pharma Mar SA, Subsidiaries 31
List of Figures
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Pharma Mar SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Pharma Mar SA, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer